title: [Verapamil and nitrendipine in beta blocker-resistant hypertensive patients].
authors.forename: D
authors.initials: D
authors.lastname: Edmonds
authors.forename: E
authors.initials: E
authors.lastname: Förster
authors.forename: M
authors.initials: M
authors.lastname: Wehling
authors.forename: W
authors.initials: W
authors.lastname: Siegenthaler
authors.forename: W
authors.initials: W
authors.lastname: Vetter
mesh_terms: D001262:Atenolol / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009568:Nitrendipine; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D002121:Calcium Channel Blockers; D001262:Atenolol; D009568:Nitrendipine; D014700:Verapamil; D009543:Nifedipine
vernacular_title: Verapamil und Nitrendipin bei betablockerresistenten Hypertonikern.